Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials

Mateos Maria-Victoria; Goldschmidt Hartmut; San-Miguel Jesus F.; Blaedel Julie; Obreja Mihaela; Yang Zhao; Szabo Zsolt; Leleu Xavier

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials

【24h】

Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials

机译：在先前治疗之后复发或难治多骨髓瘤患者的复发或难治性多发性骨髓瘤患者：分析来自随机阶段3的亚群的整体存活率，渴望和努力试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共4页
作者
Mateos Maria-Victoria; Goldschmidt Hartmut; San-Miguel Jesus F.; Blaedel Julie; Obreja Mihaela; Yang Zhao; Szabo Zsolt; Leleu Xavier;
展开▼
作者单位

Univ Hosp Salamanca Salamanca Spain;

Heidelberg Med Univ Heidelberg Germany;

Clin Univ Navarra Pamplona Spain;

Amgen Inc Thousand Oaks CA 91320 USA;

Amgen Inc Thousand Oaks CA 91320 USA;

Amgen Inc Thousand Oaks CA 91320 USA;

Amgen GmbH Zug Switzerland;

CHU Poitiers Poitiers France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials [J] . Mateos Maria-Victoria, Goldschmidt Hartmut, San-Miguel Jesus F., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：在先前治疗之后复发或难治多骨髓瘤患者的复发或难治性多发性骨髓瘤患者：分析来自随机阶段3的亚群的整体存活率，渴望和努力试验
2. Carfilzomib (K) in Relapsed and Refractory Multiple Myeloma (RRMM): Frailty Subgroup Analysis from Phase 3 ASPIRE and ENDEAVOR [J] . Facon Thierry, Niesvizky Ruben, Weisel Katja, Clinical lymphoma, myeloma & leukemia . 2019,第Suppla1期

机译：Carfilzomib（k）复发和难治性多发性骨髓瘤（RRMM）：来自第3阶段渴望和努力的脆弱子组分析
3. Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial [J] . Dimopoulos Meletios A., Goldschmidt Hartmut, Niesvizky Ruben, The lancet oncology . 2017,第10期

机译：Carfilzomib或Bortezomib复发或难以多发性骨髓瘤（努力）：开放标签，随机，第3阶段试验的临时总生存分析
4. Durability of Response with Thalidomide Therapy for Relapsed Multiple Myeloma [C] . B. Myers, S.G. Jones, G. Do I an European Haematology Association . 2002

机译：耐久性耐久性与多发性骨髓瘤复发疗法
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Health-Related Quality-of-Life Results From the Open-Label Randomized Phase III ASPIRE Trial Evaluating Carfilzomib Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma [O] . A. Keith Stewart, Meletios A. Dimopoulos, Tamás Masszi, -1

机译：评估卡非佐米来那度胺和地塞米松与来那度胺和地塞米松在复发性多发性骨髓瘤患者中的开放标签随机III期ASPIRE试验与健康相关的生活质量结果
7. Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials [O] . Katja Weisel, Istvan Majer, Lucy DeCosta, 2019

机译：Carfilzomib和地塞米松与八个脊髓甲基米塞和地塞米松，复发或难治性多发性骨髓瘤的患者：使用来自第3阶段的数据和蓖麻试验的间接比较

Carfilzomib in Relapsed or Refractory Multiple Myeloma Patients with Early or Late Relapse Following Prior Therapy: An Analysis of Overall Survival in Subgroups from the Randomized Phase 3 Aspire and Endeavor Trials

著录项

相似文献

相关主题

期刊订阅